{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:30:46Z","timestamp":1757705446918,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,10,22]],"date-time":"2016-10-22T00:00:00Z","timestamp":1477094400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI14C1812"],"award-info":[{"award-number":["HI14C1812"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Oral Invest"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00784-016-1973-2","type":"journal-article","created":{"date-parts":[[2016,10,22]],"date-time":"2016-10-22T16:38:36Z","timestamp":1477154316000},"page":"1905-1911","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A retrospective study of osteomyelitis and osteonecrosis of the jaws and its etiologic implication of bisphosphonate in Asians"],"prefix":"10.1007","volume":"21","author":[{"given":"Sung Ok","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chae-Yoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junho","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deog-Yoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9620-4814","authenticated-orcid":false,"given":"Yong-Dae","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,22]]},"reference":[{"key":"1973_CR1","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-540-28766-7","volume-title":"Osteomyelitis of the jaws","author":"MM Baltensperger","year":"2009","unstructured":"Baltensperger MM, Eyrich GK (2009) Osteomyelitis of the jaws. Springer, Berlin Heidelberg"},{"issue":"9","key":"1973_CR2","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s00784-014-1205-6","volume":"18","author":"C Walter","year":"2014","unstructured":"Walter C, Sagheb K, Bitzer J et al (2014) Analysis of reasons for osteonecrosis of the jaws. Clin Oral Invest 18(9):2221\u20132226. doi:\n10.1007\/s00784-014-1205-6","journal-title":"Clin Oral Invest"},{"key":"1973_CR3","unstructured":"Administration USFD (2006) FDA approves new treatment for gastrointestinal and kidney cancer. Jan 26 ed"},{"issue":"3","key":"1973_CR4","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.joms.2011.02.104","volume":"70","author":"RN Hopp","year":"2012","unstructured":"Hopp RN, Pucci J, Santos-Silva AR et al (2012) Osteonecrosis after administration of intravitreous bevacizumab. J Oral Maxillofac Surg: Off J Am Assoc Oral Maxillofac Surg 70(3):632\u2013635. doi:\n10.1016\/j.joms.2011.02.104","journal-title":"J Oral Maxillofac Surg: Off J Am Assoc Oral Maxillofac Surg"},{"issue":"24","key":"1973_CR5","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1200\/JCO.2007.15.5424","volume":"26","author":"CL Estilo","year":"2008","unstructured":"Estilo CL, Fornier M, Farooki A et al (2008) Osteonecrosis of the jaw related to bevacizumab. J Clin Oncol: Off J Am Soc Clin Oncol 26(24):4037\u20134038. doi:\n10.1200\/JCO.2007.15.5424","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"issue":"4","key":"1973_CR6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.tripleo.2010.04.049","volume":"110","author":"S Hoefert","year":"2010","unstructured":"Hoefert S, Eufinger H (2010) Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw: presentation of three cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 110(4):463\u2013469. doi:\n10.1016\/j.tripleo.2010.04.049","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"2","key":"1973_CR7","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/j.oraloncology.2011.07.030","volume":"48","author":"U Disel","year":"2012","unstructured":"Disel U, Besen AA, Ozyilkan O et al (2012) A case report of bevacizumab-related osteonecrosis of the jaw: old problem, new culprit. Oral Oncol 48(2):e2\u2013e3. doi:\n10.1016\/j.oraloncology.2011.07.030","journal-title":"Oral Oncol"},{"issue":"3","key":"1973_CR8","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.tripleo.2011.06.023","volume":"113","author":"Y Fleissig","year":"2012","unstructured":"Fleissig Y, Regev E, Lehman H (2012) Sunitinib related osteonecrosis of jaw: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol 113(3):e1\u2013e3. doi:\n10.1016\/j.tripleo.2011.06.023","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"2","key":"1973_CR9","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.4317\/medoral.16.e137","volume":"16","author":"C Salort-Llorca","year":"2011","unstructured":"Salort-Llorca C, Minguez-Serra MP, Silvestre-Donat FJ (2011) Maxillary osteonecrosis associated to antiangiogenic drugs. Med Oral, Patologia Oral y Cirugia Bucal 16(2):e137\u2013e138","journal-title":"Med Oral, Patologia Oral y Cirugia Bucal"},{"issue":"9768","key":"1973_CR10","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","volume":"377","author":"K Fizazi","year":"2011","unstructured":"Fizazi K, Carducci M, Smith M et al (2011) Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet 377(9768):813\u2013822. doi:\n10.1016\/S0140-6736(10)62344-6","journal-title":"Lancet"},{"key":"1973_CR11","volume-title":"Oral and intravenous bisphosphonate-induced osteonecrosis of the jaws","author":"R Marx","year":"2011","unstructured":"Marx R (2011) Oral and intravenous bisphosphonate-induced osteonecrosis of the jaws. Quintessence, Hanover Park, Il"},{"key":"1973_CR12","doi-asserted-by":"crossref","unstructured":"Cosman F, de Beur SJ, LeBoff MS et al (2014) Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359\u20132381","DOI":"10.1007\/s00198-014-2794-2"},{"issue":"4","key":"1973_CR13","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00198-013-2595-z","volume":"25","author":"JW Kim","year":"2014","unstructured":"Kim JW, Jeon YJ, Baek DH et al (2014) Percentage of the population at high risk of osteoporotic fracture in South Korea: analysis of the 2010 Fifth Korean National Health and Nutrition Examination survey data. Osteoporos Int 25(4):1313\u20131319. doi:\n10.1007\/s00198-013-2595-z","journal-title":"Osteoporos Int"},{"issue":"1","key":"1973_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00774-011-0280-x","volume":"30","author":"HJ Choi","year":"2012","unstructured":"Choi HJ, Shin CS, Ha YC et al (2012) Burden of osteoporosis in adults in Korea: a national health insurance database study. J Bone Miner Metab 30(1):54\u201358. doi:\n10.1007\/s00774-011-0280-x","journal-title":"J Bone Miner Metab"},{"issue":"1","key":"1973_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5125\/jkaoms.2013.39.1.9","volume":"39","author":"JK Lee","year":"2013","unstructured":"Lee JK, Kim KW, Choi JY et al (2013) Bisphosphonates-related osteonecrosis of the jaw in Korea: a preliminary report. J Korean Assoc Oral Maxillofac Surg 39(1):9\u201313. doi:\n10.5125\/jkaoms.2013.39.1.9","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"issue":"3","key":"1973_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.joms.2006.10.061","volume":"65","author":"T Mavrokokki","year":"2007","unstructured":"Mavrokokki T, Cheng A, Stein B et al (2007) Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg 65(3):415\u2013423. doi:\n10.1016\/j.joms.2006.10.061","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"1973_CR17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.14219\/jada.archive.2009.0019","volume":"140","author":"PP Sedghizadeh","year":"2009","unstructured":"Sedghizadeh PP, Stanley K, Caligiuri M et al (2009) Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw. J Am Dent Assoc 140(1):61\u201366","journal-title":"J Am Dent Assoc"},{"issue":"4","key":"1973_CR18","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/pds.3562","volume":"23","author":"E Sumi","year":"2014","unstructured":"Sumi E, Yamazaki T, Tanaka S et al (2014) The increase in prescriptions of bisphosphonates and the incidence proportion of osteonecrosis of the jaw after risk communication activities in Japan: a hospital-based cohort study. Pharmacoepidemiol Drug Saf 23(4):398\u2013405","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"1973_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/annonc\/mdn554","volume":"20","author":"MA Dimopoulos","year":"2009","unstructured":"Dimopoulos MA, Kastritis E, Bamia C et al (2009) Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann Oncol: Off J Eur Soc Med Oncol\/ ESMO 20(1):117\u2013120. doi:\n10.1093\/annonc\/mdn554","journal-title":"Ann Oncol: Off J Eur Soc Med Oncol\/ ESMO"},{"issue":"1","key":"1973_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/annonc\/mdr039","volume":"23","author":"AM Vandone","year":"2012","unstructured":"Vandone AM, Donadio M, Mozzati M et al (2012) Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience. Ann Oncol: Off J Eur Soc Med Oncol\/ ESMO 23(1):193\u2013200. doi:\n10.1093\/annonc\/mdr039","journal-title":"Ann Oncol: Off J Eur Soc Med Oncol\/ ESMO"},{"issue":"10","key":"1973_CR21","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J et al (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update. J Oral Maxillofac Surg: Off J Am Assoc Oral Maxillofac Surg 72(10):1938\u20131956. doi:\n10.1016\/j.joms.2014.04.031","journal-title":"J Oral Maxillofac Surg: Off J Am Assoc Oral Maxillofac Surg"},{"issue":"6","key":"1973_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0127970","volume":"10","author":"J Kim","year":"2015","unstructured":"Kim J, Shin JY, Lee J et al (2015) Comparison of the prescribing pattern of bisphosphonate and raloxifene in Korean women with osteoporosis: from a national health insurance claims database. PLoS One 10(6):e0127970. doi:\n10.1371\/journal.pone.0127970","journal-title":"PLoS One"},{"issue":"1","key":"1973_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/annonc\/mdn526","volume":"20","author":"CI Ripamonti","year":"2009","unstructured":"Ripamonti CI, Maniezzo M, Campa T et al (2009) Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. Ann Oncol: Off J Eur Soc Med Oncol\/ ESMO 20(1):137\u2013145. doi:\n10.1093\/annonc\/mdn526","journal-title":"Ann Oncol: Off J Eur Soc Med Oncol\/ ESMO"},{"issue":"11","key":"1973_CR24","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1080\/10428190802483778","volume":"49","author":"V Montefusco","year":"2008","unstructured":"Montefusco V, Gay F, Spina F et al (2008) Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates. Leukemia Lymphoma 49(11):2156\u20132162. doi:\n10.1080\/10428190802483778","journal-title":"Leukemia Lymphoma"},{"issue":"1","key":"1973_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00784-009-0266-4","volume":"14","author":"C Walter","year":"2010","unstructured":"Walter C, Klein MO, Pabst A et al (2010) Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells. Clin Oral Investig 14(1):35\u201341. doi:\n10.1007\/s00784-009-0266-4","journal-title":"Clin Oral Investig"},{"key":"1973_CR26","first-page":"423","volume":"6","author":"MD Kostoff","year":"2014","unstructured":"Kostoff MD, Saseen JJ, Borgelt LM (2014) Evaluation of fracture risk and potential drug holidays for postmenopausal women on long-term bisphosphonate therapy. Int J Women\u2019s Health 6:423","journal-title":"Int J Women\u2019s Health"},{"issue":"5","key":"1973_CR27","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3892\/br.2013.145","volume":"1","author":"T Ziebart","year":"2013","unstructured":"Ziebart T, Ziebart J, Gauss L et al (2013) Investigation of inhibitory effects on EPC-mediated neovascularization by different bisphosphonates for cancer therapy. Biomedical Rep 1(5):719\u2013722. doi:\n10.3892\/br.2013.145","journal-title":"Biomedical Rep"},{"issue":"11","key":"1973_CR28","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1007\/s00198-011-1882-9","volume":"23","author":"Y-D Kwon","year":"2012","unstructured":"Kwon Y-D, Lee D-W, Choi B-J et al (2012) Short-term teriparatide therapy as an adjunctive modality for bisphosphonate-related osteonecrosis of the jaws. Osteoporos Int 23(11):2721\u20132725","journal-title":"Osteoporos Int"},{"issue":"8","key":"1973_CR29","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3899\/jrheum.081176","volume":"36","author":"AN Lau","year":"2009","unstructured":"Lau AN, Adachi JD (2009) Resolution of osteonecrosis of the jaw after teriparatide [recombinant human PTH-(1-34)] therapy. J Rheumatol 36(8):1835\u20131837","journal-title":"J Rheumatol"},{"issue":"9","key":"1973_CR30","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hed.21380","volume":"33","author":"JJ Lee","year":"2011","unstructured":"Lee JJ, Cheng SJ, Jeng JH et al (2011) Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy. Head Neck 33(9):1366\u20131371","journal-title":"Head Neck"},{"key":"1973_CR31","doi-asserted-by":"publisher","DOI":"10.1089\/pho.2014.3742","author":"MA Altay","year":"2014","unstructured":"Altay MA, Tasar F, Tosun E et al (2014) Low-level laser therapy supported surgical treatment of bisphosphonate related osteonecrosis of jaws: a retrospective analysis of 11 cases. Photomed Laser Surg. doi:\n10.1089\/pho.2014.3742","journal-title":"Photomed Laser Surg"},{"issue":"7","key":"1973_CR32","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00784-014-1394-z","volume":"19","author":"AM Pabst","year":"2015","unstructured":"Pabst AM, Kruger M, Ziebart T et al (2015) Isoprenoid geranylgeraniol: the influence on cell characteristics of endothelial progenitor cells after bisphosphonate therapy in vitro. Clin Oral Investig 19(7):1625\u20131633. doi:\n10.1007\/s00784-014-1394-z","journal-title":"Clin Oral Investig"},{"issue":"12","key":"1973_CR33","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.joms.2007.08.003","volume":"65","author":"RE Marx","year":"2007","unstructured":"Marx RE, Cillo JE Jr, Ulloa JJ (2007) Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 65(12):2397\u20132410","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"1973_CR34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-0501.2010.01965.x","volume":"22","author":"YD Kwon","year":"2011","unstructured":"Kwon YD, Ohe JY, Kim DY et al (2011) Retrospective study of two biochemical markers for the risk assessment of oral bisphosphonate-related osteonecrosis of the jaws: can they be utilized as risk markers? Clin Oral Implants Res 22(1):100\u2013105","journal-title":"Clin Oral Implants Res"},{"issue":"9","key":"1973_CR35","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.joms.2009.04.051","volume":"67","author":"V Thumbigere-Math","year":"2009","unstructured":"Thumbigere-Math V, Sabino MAC, Gopalakrishnan R et al (2009) Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients. J Oral Maxillofac Surg 67(9):1904\u20131913","journal-title":"J Oral Maxillofac Surg"},{"issue":"4","key":"1973_CR36","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10006-012-0363-4","volume":"17","author":"PN Lambade","year":"2013","unstructured":"Lambade PN, Lambade D, Goel M (2013) Osteoradionecrosis of the mandible: a review. Oral Maxillofac Surg 17(4):243\u2013249. doi:\n10.1007\/s10006-012-0363-4","journal-title":"Oral Maxillofac Surg"},{"issue":"10","key":"1973_CR37","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.oraloncology.2012.03.028","volume":"48","author":"S Kuhl","year":"2012","unstructured":"Kuhl S, Walter C, Acham S et al (2012) Bisphosphonate-related osteonecrosis of the jaws\u2014a review. Oral Oncol 48(10):938\u2013947. doi:\n10.1016\/j.oraloncology.2012.03.028","journal-title":"Oral Oncol"}],"container-title":["Clinical Oral Investigations"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00784-016-1973-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-016-1973-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00784-016-1973-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T03:48:45Z","timestamp":1495511325000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00784-016-1973-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,22]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["1973"],"URL":"https:\/\/doi.org\/10.1007\/s00784-016-1973-2","relation":{},"ISSN":["1432-6981","1436-3771"],"issn-type":[{"type":"print","value":"1432-6981"},{"type":"electronic","value":"1436-3771"}],"subject":[],"published":{"date-parts":[[2016,10,22]]}}}